Teva Pharmaceutical Industries Ltd
Close on Oct 19, 2026Market cap $48.13BP/E 68.9Yield –
Teva Pharmaceutical Industries Manufacturing & R&D Facilities — Europe by Year
Teva Pharmaceutical Industries Manufacturing & R&D Facilities — Europe: 23 in FY2025, down 8.0% from a year earlier. That is the lowest of the 9 years on record here.
Where the FY2025 figure comes from
“|| Europe | 23 | 8,878”
Source: Form 10-K (0001193125-26-034532) ↗
Reported in SEC Form 10-K (Item 2. Properties).
annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Manufacturing & R&D Facilities — Europe | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 23 | -8.0% | Form 10-K (0001193125-26-034532) ↗ |
| FY2024 | Dec 31, 2024 | 25 | 0.0% | Form 10-K (0001193125-25-020826) ↗ |
| FY2023 | Dec 31, 2023 | 25 | -28.6% | Form 10-K (0001193125-24-031005) ↗ |
| FY2022 | Dec 31, 2022 | 35 | +16.7% | Form 10-K (0001193125-23-031250) ↗ |
| FY2021 | Dec 31, 2021 | 30 | -6.2% | Form 10-K (0001193125-22-032667) ↗ |
| FY2020 | Dec 31, 2020 | 32 | -5.9% | Form 10-K (0001193125-21-036239) ↗ |
| FY2019 | Dec 31, 2019 | 34 | +9.7% | Form 10-K (0001193125-20-044221) ↗ |
| FY2018 | Dec 31, 2018 | 31 | -6.1% | Form 10-K (0001193125-19-043564) ↗ |
| FY2017 | Dec 31, 2017 | 33 | – | Form 10-K (0001193125-18-039076) ↗ |
Cite this data
StockData. (2026). Teva Pharmaceutical Industries Manufacturing & R&D Facilities — Europe, annual FY2017–FY2025 [Data set]. Compiled from Teva Pharmaceutical Industries SEC filings and investor materials. https://stockdatahq.com/stocks/teva/kpis/fac-eur-count
See every metric in the Teva Pharmaceutical Industries KPI table. Data updated Nov 10, 2026.
See a number that looks wrong?